BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+9.35%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$846M
AUM Growth
+$846M
(+13%)
Cap. Flow
+$40.5M
Cap. Flow
% of AUM
4.78%
Top 10 Holdings %
Top 10 Hldgs %
28.99%
Holding
143
New
11
Increased
57
Reduced
23
Closed
11
Top Buys
| 1 |
Integra LifeSciences
IART
|
$7.92M |
| 2 |
Edwards Lifesciences
EW
|
$7.67M |
| 3 |
Cigna
CI
|
$6.73M |
| 4 |
IQVIA
IQV
|
$5.95M |
| 5 |
Labcorp
LH
|
$5.91M |
Top Sells
| 1 |
AKRX
Akorn, Inc.
AKRX
|
$11.9M |
| 2 |
Centene
CNC
|
$9.87M |
| 3 |
Incyte
INCY
|
$8M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$6.69M |
| 5 |
ALR
Alere Inc
ALR
|
$5.78M |
Sector Composition
| 1 | Healthcare | 92.73% |
| 2 | Financials | 0.93% |
| 3 | Industrials | 0.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Stryker
SYK
$150B
| $11.7M | 1.38% | 84,300 -38,270 | -31% | -$5.31M |
|
27
Ionis Pharmaceuticals
IONS
$6.8B
| $11.4M | 1.35% | 224,562 +19,309 | +9% | +$982K |
|
28
Zimmer Biomet
ZBH
$21B
| $11.3M | 1.34% | 88,000 | – | – |
|
|
ALXN
29
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $11.2M | 1.32% | 92,000 +21,000 | +30% | +$2.56M |
|
30
Cencora
COR
$56.5B
| $10.7M | 1.26% | 113,058 +10,959 | +11% | +$1.04M |
|
|
EGRX
31
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $10.4M | 1.23% | 131,990 +64,290 | +95% | +$5.07M |
|
32
Viatris
VTRS
$12.3B
| $10.2M | 1.21% | 263,200 +6,000 | +2% | +$233K |
|
33
Becton Dickinson
BDX
$55.3B
| $10.1M | 1.2% | 52,000 +22,000 | +73% | +$4.29M |
|
34
Alnylam Pharmaceuticals
ALNY
$58.5B
| $9.97M | 1.18% | 125,029 -16,871 | -12% | -$1.35M |
|
35
Teva Pharmaceuticals
TEVA
$21.1B
| $9.48M | 1.12% | 285,329 -80,843 | -22% | -$2.69M |
|
|
WMGI
36
DELISTED
Wright Medical Group Inc
WMGI
| $9.24M | 1.09% | 336,055 +47,392 | +16% | +$1.3M |
|
|
SHPG
37
DELISTED
Shire pic
SHPG
| $8.91M | 1.05% | 53,885 -11,815 | -18% | -$1.95M |
|
38
Vertex Pharmaceuticals
VRTX
$100B
| $8.82M | 1.04% | 68,400 -7,600 | -10% | -$979K |
|
|
39
Integra LifeSciences
IART
$1.18B
| $8.74M | 1.03% | 160,350 +145,350 | +969% | +$7.92M |
|
|
HRC
40
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $8.32M | 0.98% | 104,503 +2,229 | +2% | +$177K |
|
41
AbbVie
ABBV
$372B
| $8.31M | 0.98% | 114,574 +11,873 | +12% | +$861K |
|
|
MNK
42
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $8.29M | 0.98% | 184,945 +2,220 | +1% | +$99.5K |
|
43
Alkermes
ALKS
$4.78B
| $7.98M | 0.94% | 137,600 +98,100 | +248% | +$5.69M |
|
|
44
Labcorp
LH
$23.1B
| $7.92M | 0.94% | 51,370 +38,370 | +295% | +$5.91M |
|
|
AET
45
DELISTED
Aetna Inc
AET
| $7.87M | 0.93% | 51,800 +9,200 | +22% | +$1.4M |
|
|
46
Ligand Pharmaceuticals
LGND
$3.15B
| $7.7M | 0.91% | 63,400 -55,140 | -47% | -$6.69M |
|
47
Perrigo
PRGO
$3.27B
| $7.29M | 0.86% | 96,468 +2,057 | +2% | +$155K |
|
|
AGN
48
DELISTED
Allergan plc
AGN
| $7.05M | 0.83% | 29,000 | – | – |
|
49
Humana
HUM
$36.5B
| $6.38M | 0.75% | 26,500 +7,500 | +39% | +$1.8M |
|
50
Tenet Healthcare
THC
$16.3B
| $6.35M | 0.75% | 328,506 +2,960 | +0.9% | +$57.2K |
|